Report Detail
Global Genital Herpes Treatment Drugs Market Size, Status and Forecast 2019-2025
- RnM3635414 |
- 30 July, 2019 |
- Global |
- 94 Pages |
- QYResearch |
- Pharma & Healthcare
Genital herpes is a sexually transmitted disease (STD). This STD causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid. About 16 percentTrusted Source of people between the ages of 14 and 49 have this STD.
In 2018, the global Genital Herpes Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Genital Herpes Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Genital Herpes Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
AstraZeneca, Plc.
Apotheca, Inc.
Asahi Kasei Pharma Corporation
Carlsbad Technology, Inc.
GlaxoSmithkline, Plc.
Mylan N.V.
Novartis AG.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Zydus Pharmaceuticals, Inc.
Market segment by Type, the product can be split into
Acyclovir
Famciclovir
Valacyclovir
Market segment by Application, split into
Hospitals
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Genital Herpes Treatment Drugs status, future forecast, growth opportunity, key market and key players.
To present the Genital Herpes Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Genital Herpes Treatment Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Genital Herpes Treatment Drugs Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Acyclovir
- 1.4.3 Famciclovir
- 1.4.4 Valacyclovir
- 1.5 Market by Application
- 1.5.1 Global Genital Herpes Treatment Drugs Market Share by Application (2019-2025)
- 1.5.2 Hospitals
- 1.5.3 Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Genital Herpes Treatment Drugs Market Size
- 2.2 Genital Herpes Treatment Drugs Growth Trends by Regions
- 2.2.1 Genital Herpes Treatment Drugs Market Size by Regions (2019-2025)
- 2.2.2 Genital Herpes Treatment Drugs Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Genital Herpes Treatment Drugs Market Size by by Players
- 3.1.1 Global Genital Herpes Treatment Drugs Revenue by by Players (2014-2019)
- 3.1.2 Global Genital Herpes Treatment Drugs Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Genital Herpes Treatment Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Genital Herpes Treatment Drugs Key Players Head office and Area Served
- 3.3 Key Players Genital Herpes Treatment Drugs Product/Solution/Service
- 3.4 Date of Enter into Genital Herpes Treatment Drugs Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Genital Herpes Treatment Drugs Market Size by Type (2014-2019)
- 4.2 Global Genital Herpes Treatment Drugs Market Size by Application (2014-2019)
5 North America
- 5.1 North America Genital Herpes Treatment Drugs Market Size (2014-2019)
- 5.2 Genital Herpes Treatment Drugs Key Players in North America
- 5.3 North America Genital Herpes Treatment Drugs Market Size by Type
- 5.4 North America Genital Herpes Treatment Drugs Market Size by Application
6 Europe
- 6.1 Europe Genital Herpes Treatment Drugs Market Size (2014-2019)
- 6.2 Genital Herpes Treatment Drugs Key Players in Europe
- 6.3 Europe Genital Herpes Treatment Drugs Market Size by Type
- 6.4 Europe Genital Herpes Treatment Drugs Market Size by Application
7 China
- 7.1 China Genital Herpes Treatment Drugs Market Size (2014-2019)
- 7.2 Genital Herpes Treatment Drugs Key Players in China
- 7.3 China Genital Herpes Treatment Drugs Market Size by Type
- 7.4 China Genital Herpes Treatment Drugs Market Size by Application
8 Japan
- 8.1 Japan Genital Herpes Treatment Drugs Market Size (2014-2019)
- 8.2 Genital Herpes Treatment Drugs Key Players in Japan
- 8.3 Japan Genital Herpes Treatment Drugs Market Size by Type
- 8.4 Japan Genital Herpes Treatment Drugs Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Genital Herpes Treatment Drugs Market Size (2014-2019)
- 9.2 Genital Herpes Treatment Drugs Key Players in Southeast Asia
- 9.3 Southeast Asia Genital Herpes Treatment Drugs Market Size by Type
- 9.4 Southeast Asia Genital Herpes Treatment Drugs Market Size by Application
10 India
- 10.1 India Genital Herpes Treatment Drugs Market Size (2014-2019)
- 10.2 Genital Herpes Treatment Drugs Key Players in India
- 10.3 India Genital Herpes Treatment Drugs Market Size by Type
- 10.4 India Genital Herpes Treatment Drugs Market Size by Application
11 Central & South America
- 11.1 Central & South America Genital Herpes Treatment Drugs Market Size (2014-2019)
- 11.2 Genital Herpes Treatment Drugs Key Players in Central & South America
- 11.3 Central & South America Genital Herpes Treatment Drugs Market Size by Type
- 11.4 Central & South America Genital Herpes Treatment Drugs Market Size by Application
12 International Players Profiles
- 12.1 AstraZeneca, Plc.
- 12.1.1 AstraZeneca, Plc. Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Genital Herpes Treatment Drugs Introduction
- 12.1.4 AstraZeneca, Plc. Revenue in Genital Herpes Treatment Drugs Business (2014-2019))
- 12.1.5 AstraZeneca, Plc. Recent Development
- 12.2 Apotheca, Inc.
- 12.2.1 Apotheca, Inc. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Genital Herpes Treatment Drugs Introduction
- 12.2.4 Apotheca, Inc. Revenue in Genital Herpes Treatment Drugs Business (2014-2019)
- 12.2.5 Apotheca, Inc. Recent Development
- 12.3 Asahi Kasei Pharma Corporation
- 12.3.1 Asahi Kasei Pharma Corporation Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Genital Herpes Treatment Drugs Introduction
- 12.3.4 Asahi Kasei Pharma Corporation Revenue in Genital Herpes Treatment Drugs Business (2014-2019)
- 12.3.5 Asahi Kasei Pharma Corporation Recent Development
- 12.4 Carlsbad Technology, Inc.
- 12.4.1 Carlsbad Technology, Inc. Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Genital Herpes Treatment Drugs Introduction
- 12.4.4 Carlsbad Technology, Inc. Revenue in Genital Herpes Treatment Drugs Business (2014-2019)
- 12.4.5 Carlsbad Technology, Inc. Recent Development
- 12.5 GlaxoSmithkline, Plc.
- 12.5.1 GlaxoSmithkline, Plc. Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Genital Herpes Treatment Drugs Introduction
- 12.5.4 GlaxoSmithkline, Plc. Revenue in Genital Herpes Treatment Drugs Business (2014-2019)
- 12.5.5 GlaxoSmithkline, Plc. Recent Development
- 12.6 Mylan N.V.
- 12.6.1 Mylan N.V. Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Genital Herpes Treatment Drugs Introduction
- 12.6.4 Mylan N.V. Revenue in Genital Herpes Treatment Drugs Business (2014-2019)
- 12.6.5 Mylan N.V. Recent Development
- 12.7 Novartis AG.
- 12.7.1 Novartis AG. Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Genital Herpes Treatment Drugs Introduction
- 12.7.4 Novartis AG. Revenue in Genital Herpes Treatment Drugs Business (2014-2019)
- 12.7.5 Novartis AG. Recent Development
- 12.8 Merck & Co., Inc.
- 12.8.1 Merck & Co., Inc. Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Genital Herpes Treatment Drugs Introduction
- 12.8.4 Merck & Co., Inc. Revenue in Genital Herpes Treatment Drugs Business (2014-2019)
- 12.8.5 Merck & Co., Inc. Recent Development
- 12.9 Teva Pharmaceutical Industries Ltd.
- 12.9.1 Teva Pharmaceutical Industries Ltd. Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Genital Herpes Treatment Drugs Introduction
- 12.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Genital Herpes Treatment Drugs Business (2014-2019)
- 12.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
- 12.10 Zydus Pharmaceuticals, Inc.
- 12.10.1 Zydus Pharmaceuticals, Inc. Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Genital Herpes Treatment Drugs Introduction
- 12.10.4 Zydus Pharmaceuticals, Inc. Revenue in Genital Herpes Treatment Drugs Business (2014-2019)
- 12.10.5 Zydus Pharmaceuticals, Inc. Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Genital Herpes Treatment Drugs. Industry analysis & Market Report on Genital Herpes Treatment Drugs is a syndicated market report, published as Global Genital Herpes Treatment Drugs Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Genital Herpes Treatment Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
